GlassScriptPhysician profile
Ashley Savannah Roberson
NPI 1730835737
$1,385.91
in general payments reported to CMS, 2019-2025
9 companies · $1,246 in 2025
The $1,246 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $60.88 · 2023: $20.53 · 2024: $58.55 · 2025: $1,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,029 · Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,029.30 |
| Food and Beverage | $295.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,154.49 | 2024-2025 | Iovera, Zilretta, Exparel |
| Innovation Technologies INC | $55.77 | 2025 | Irrisept |
| Boston Scientific Corporation | $42.36 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $33.71 | 2024-2025 | |
| Gentleman Orthopedic Solutions | $30.55 | 2022 | |
| Davol INC. | $20.53 | 2023 | |
| Smith+Nephew, INC. | $18.17 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Si-Bone, INC. | $17.00 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Roberson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.